It's Johnson & Johnson, 38 million; Medicago, 76 million; Novavax, 76 million; Sanofi, 72 million.
Through you, Mr. Chair, you can't go to the public bragging about how diverse your portfolio is while continuing to hoard vaccines and take from COVAX while blocking the TRIPS waiver. You can't do that. You can't have it all ways.